3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Myelodysplastic Syndromes
8
Hodgkin Disease
7
Burkitt Lymphoma
5
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Hematologic Neoplasms
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Neoplasms
3
Rhabdomyosarcoma
2
Myeloproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Teratoma
1
Solid Tumors
1
Sarcoma
1
Recurrence
1
Myelodysplastic-Myeloproliferative Diseases
1
Multi-centric Castleman's Disease
1
Malignant mesenchymal tumor
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell
1
Interventions
pegaspargase
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Asparaginase
2
tislelizumab
1
sugemalimab
1
selinexor
1
pembrolizumab
1
fludarabine
1
Vorinostat
1
Transplantation
1
Tomography, X-Ray Computed
1
Sirolimus
1
Methylprednisolone
1
Methotrexate
1
Melphalan
1
IMC-001
1
Cyclosporine
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Filgrastim
×
90 days
×
Clear all
No trials found.